Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
NCT01382810 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2012-06-14
Summary
The purpose of this study is to evaluate and compare the effects of Altaire Gel forming solution and Refresh Tears in mild-moderate dry eye patients.
Conditions
- Dry Eye Syndromes
Interventions
- DRUG
-
Altaire Gel forming solution
Three times a day for two months
- DRUG
-
Refresh Tears
Three times a day for two months
Sponsors & Collaborators
-
Innovative Medical
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2012-10-31
- Completion
- 2012-10-31
Countries
- United States
Study Locations
More Related Trials
-
Safety/Efficacy of Systane Free vs Refresh Tears
NCT00348322 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)
NCT03223909 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops
NCT01160133 ·Status: COMPLETED ·Phase: NA
-
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
NCT01386073 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes
NCT00704275 ·Status: UNKNOWN ·Phase: PHASE4
-
Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome
NCT01382225 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye
NCT03183089 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION
NCT02470429 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
NCT02455050 ·Status: COMPLETED ·Phase: PHASE3
-
Tear Lipid Layer Thickness With Emollient Eye Drops
NCT03380624 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
NCT03502447 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
NCT04393441 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
NCT01682460 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
NCT01657253 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome
NCT01541891 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Systane Free vs. Saline in the Treatment of Dry Eye
NCT00388791 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00399061 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Trial to Assess Subjects With Dry Eye Disease.
NCT04971031 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye
NCT02420730 ·Status: COMPLETED ·Phase: PHASE1